ArticleChild and adolescent psychiatry and mental health2026
Depression and anxiety symptoms among Kenyan adolescents: psychometric validation, prevalence, network analysis, and psychosocial determinants.
Article in Child and adolescent psychiatry and mental health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
backgroundAdolescent mental health in Sub-Saharan Africa remains critically understudied despite high burden estimates. We assessed the psychometric properties of Western-derived instruments, prevalence of depression and anxiety symptoms, associations with psychosocial and sociodemographic factors, and symptom network structures in a large multi-year sample of Kenyan adolescents.
methodsWe administered depression (PHQ-8), anxiety (GAD-7), social support, perceived control, and wellbeing measures to 7865 Kenyan secondary school students aged 12-20 across three studies (2021-2023).
resultsBoth PHQ-8 (α = 0.70) and GAD-7 (α = 0.78) demonstrated adequate reliability, and confirmatory factor analyses supported unidimensional structures with acceptable fit (PHQ-8: RMSEA = 0.052, CFI = 0.945; GAD-7: RMSEA = 0.056, CFI = 0.970). Overall, 30.3% (95% CI 29.3-31.3%) and 25.1% (95% CI 24.2-26.1%) of participants met the ≥ 10 cut-off for clinically elevated depression and anxiety symptoms, respectively, with descriptive variation across study years (2021: 42.1% [39.6, 44.6%], 37.5% [35.1, 40.0%]; 2022: 25.3% [23.8, 26.8%], 21.7% [20.3, 23.2%]; 2023: 29.7% [28.1, 31.3%], 22.5% [21.1-24.0%]); direct year-on-year comparison is limited by differences in wave composition. Mixed-effects modelling identified social support (B = - 0.08) and perceived control (B = - 0.29 for depression, B = - 0.24 for anxiety) as robust protective factors. Final-year students showed elevated symptoms (B = 0.93, B = 0.77), as did students in girls' schools relative to mixed schools (B = 1.35, B = 1.27). Perceived academic ability showed a strong inverse gradient with both outcomes (excellent ability: B = - 2.51 for depression, B = - 1.76 for anxiety). Network analysis identified worry-related symptoms as most central, with hopelessness and nervousness serving as the primary bridges between depression and anxiety domains. DISCUSSION: Western-derived measures demonstrated adequate psychometric properties with Kenyan adolescents. Depression and anxiety were highly prevalent and varied by sex, school form, and school type. Social support and perceived control were the strongest protective factors; academic pressure and girls' school attendance were associated with elevated symptoms. Network analyses identify worry, hopelessness, and negative self-evaluation as possible candidate intervention targets warranting empirical evaluation. These findings underscore the urgent need for contextually grounded, school-based mental health provision in Kenya and comparable Sub-Saharan African settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.